Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_assertion type Assertion NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_head.
- NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_assertion description "[Ewing sarcoma is the prototypical member of this group of sarcomas; it was the first to be recognized pathologically as a singular entity and to have its signature translocation defined cytogenetically, which led to the identification of its key driver alteration, the EWS-FLI1 gene fusion that encodes this aberrant, chimeric transcription factor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_provenance.
- NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_assertion evidence source_evidence_literature NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_provenance.
- NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_assertion SIO_000772 21942527 NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_provenance.
- NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_assertion wasDerivedFrom befree-20150227 NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_provenance.
- NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_assertion wasGeneratedBy ECO_0000203 NP388100.RAUY9MLHQqdP75_vlECTPUcWfyUSOafPKbkR3smHAl898130_provenance.